In vitro screening model for the detection of agents active against myelogenous leukemia

Cancer Investigation

Volumn 16, Issue 5, 1998, Pages 303-308

  Edelstein, Mark ^a,b   Corbett, Thomas ^a   Valeriote, Fred ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILEUKEMIC AGENT;

ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CELL STRAIN HL 60; CELL STRAIN K 562; COLONY FORMING UNIT GM; CYTOTOXICITY; DOSE RESPONSE; DRUG SCREENING; DRUG SENSITIVITY; HUMAN; HUMAN CELL; LEUKEMIA L 1210; MOUSE; MYELOID LEUKEMIA; NONHUMAN; PRIORITY JOURNAL;

EID: 0031841148     PISSN: 07357907     EISSN: None     Source Type: Journal    
DOI: 10.3109/07357909809084648     Document Type: Article

References (4)

1. Valeriote F, Corbett T, Edelstein M, Baker L: New in vitro screening model for the discovery of antileukemic anticancer agents. Cancer Invest 14:124-142, 1996.
2. Corbett T, Valeriote F, Baker L: Is the P388 murine tumor no longer adequate as a drug discovery model? Invest New Drugs 5:3-20, 1987.
3. Cavanaugh PF, Mattes K: Large scale anticancer drug screening at Sterling Drug Inc. In: Anticancer Drug Discovery and Development, edited by F Valeriote, T Corbett, L Baker. Boston, Kluwer Academic Publishers, 1992, pp 197-245.
4. Corbett T, Valeriote FA, Polin L, et al: Discovery of solid tumor active agents using a soft-agar-colon-formation disk-diffusion assay. In: Cytotoxic Anticancer Drugs: Models and Concepts for Drug Discovery and Development, edited by FA Valeriote, TH Corbett, LH Baker. Boston, Kluwer Academic Publishers, 1992, pp 35-87.